Morning Briefing
Summaries of health policy coverage from major news organizations
Indian Drugmaker Seeks To Make, Sell Generic Version Of Pfizer's HIV Drug
The Indian drugmaker Natco Pharma "said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company's [drug] maraviroc for treating the HIV infection under a so-called 'compulsory license' [CL]," Dow Jones Newswires/Smart Money reports. "Natco Pharma's move is significant because, if successful, the Indian generic drug maker will set a precedent for other Indian companies to override multinational drug makers' patents for the treatments of diseases ranging from cancer to hypertension," according to the new service.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
